SCHEMBL14096705

SCHEMBL14096705

O=C(c1ccc2c(c1)C(c1ccccc1)(c1ccccc1)c1cc3c4c(cccc4c1-2)C(c1ccccc1)(c1ccccc1)c1cc(C(=O)c2ccccc2-c2ccccc2)ccc1-3)c1ccccc1-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 10/20 0.36
▸ CYP2C8 P10632 1/20 0.34
▸ MAPK13 O15264 1/20 0.34
▸ MAPK12 P53778 1/20 0.34
▸ MAPK11 Q15759 1/20 0.34
▸ MAPK14 Q16539 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ HNF4A P41235 1/20 0.33
▸ CHRNB2 P17787 2/20 0.32
▸ CHRNA4 P43681 2/20 0.32
▸ CHRNB4 P30926 1/20 0.32
▸ CHRNA3 P32297 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14606156 0.89 CYP2C8 (0.30) CYP2C8
SCHEMBL13423248 0.80 PDK2 (0.43) PDK2CYP2C8MAPK13MAPK12MAPK11
SCHEMBL13423255 0.80 PDK2 (0.43) PDK2CYP2C8MAPK13MAPK12MAPK11
SCHEMBL29307110 0.78 PDK2 (0.48) PDK2CYP2C8MAPK13MAPK12MAPK11
SCHEMBL14096680 0.76 ALDH1A1 (0.40) PDK2CYP2C8MAPK13MAPK12MAPK11
SCHEMBL26503482 0.73 PDK2 (0.56) PDK2MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL14096706 0.72 — —
SCHEMBL10227419 0.71 CYP2C8 (0.46) PDK2CYP2C8MAPK13MAPK12MAPK11
SCHEMBL1638586 0.71 CYP2C8 (0.43) PDK2CYP2C8MAPK13MAPK12MAPK11
SCHEMBL13507565 0.71 PDK2 (0.31) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3211058-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-08-23 — — EP disclosed
EP-3211058-A1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2017-08-30 — — EP disclosed
US-8748010-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-06-10 — — US disclosed
US-8748010-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-06-10 — — US disclosed
US-20080193797-A1 Novel Materials for Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-08-14 — — US disclosed
US-20080193797-A1 Novel Materials for Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080193797-A1 Novel Materials for Organic Electroluminescent Devices SLC40A1, SLC67A1, SLC29A1 PDK2 2432/4885CYP2C8 3975/4885MAPK13 3201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback